This resolution designates June 15, 2026, as World Elder Abuse Awareness Day and the month of June 2026 as Elder Abuse Awareness Month. It formally recognizes the efforts of various professionals, including judges, social workers, and law enforcement, who work to prevent and address abuse against older adults. The bill also encourages the public and government agencies to continue collaborating on awareness campaigns and to report cases of elder abuse, neglect, and financial exploitation.
This resolution directs the Senate Legal Counsel to file a lawsuit on behalf of the Senate to enforce the Foreign Emoluments Clause of the U.S. Constitution, which prohibits the President from accepting gifts or payments from foreign governments without Congressional approval. The bill specifically targets alleged violations by President Donald J. Trump, citing instances such as accepting a refurbished aircraft from Qatar, cryptocurrency investments from foreign-linked entities, and real estate deals in various countries that generated income for the President and his family. By seeking a court injunction, the measure aims to stop the President from accepting these specific benefits unless Congress provides its consent.
The Social Security 2100 Act proposes significant changes to the U.S. retirement system, aiming to strengthen benefits, consolidate the trust fund, and improve service delivery. To directly affect current and future beneficiaries, the bill increases monthly payments for low earners, adjusts cost-of-living calculations to better reflect inflation, and extends eligibility for children in college. It also introduces new credits for caregivers, removes waiting periods for some disability claims, and allows higher earnings to count toward future benefits. To fund these enhancements, the legislation repeals the cap on taxable wages for Social Security taxes and creates a single, unified Social Security Trust Fund. Finally, the act mandates stricter data privacy protections, prohibits the wrongful invalidation of Social Security numbers, and requires the agency to maintain a robust workforce and keep field offices open.
The Justice for Incarcerated Moms Act aims to improve maternal health outcomes for pregnant and postpartum individuals in the criminal justice system by restricting financial incentives for states that use restraints on pregnant inmates. Under the bill, states receiving federal justice grants would face a 25 percent funding penalty if they fail to implement laws limiting the use of shackles on pregnant individuals, with those withheld funds redirected to compliant states. The legislation also directs the Bureau of Prisons and the Department of Justice to create and fund programs in at least six federal facilities and across various state and local prisons that provide specialized prenatal care, mental health support, and reentry assistance. These programs are designed to address specific health disparities, particularly for racial and ethnic minority groups, by offering culturally competent care, nutrition counseling, and opportunities to maintain contact with newborn children. Additionally, the act requires an independent oversight organization to monitor program implementation and mandates a Government Accountability Office report to analyze maternal and infant health data within the correctional system.
The No Passes for Polluters Act of 2026 requires Congress to explicitly approve any exemptions from Clean Air Act regulations before the President or federal agencies can use them. Under this bill, the President must submit a detailed message to both houses of Congress explaining the reasons and facts behind any proposed exemption, which then triggers a special legislative process. To pass such an exemption, a joint resolution must be approved by a two-thirds vote in both the Senate and the House of Representatives, with limited debate and no amendments allowed. Additionally, the Comptroller General will review these proposals to ensure they have legal authority, and any unauthorized use of exemptions could lead to civil lawsuits. The legislation also mandates that the President reconsider certain executive branch emissions regulations every three years.
The Americans vs. Poisonous Pesticides Act amends federal pesticide laws to allow state courts to hear lawsuits alleging that pesticide labels fail to warn about health or environmental risks. It clarifies that a pesticide's federal registration and label approval do not automatically block these state claims, though they serve as initial evidence of compliance. The bill also permits companies to update their product labels to address new safety information without waiting for prior government approval, subject to potential review by the agency. These changes apply to both new lawsuits and cases already in progress, ensuring that federal rules do not limit existing state legal remedies for damages or injunctive relief.
This bill would establish the Julius Rosenwald and Rosenwald Schools National Historical Park, a unit of the National Park System, to honor philanthropist Julius Rosenwald and the Rosenwald Schools that educated over 600,000 African American children in the segregated South from 1912 to 1932. The park would include three restored schools (in Maryland, South Carolina, and Virginia) and a visitor center in Chicago, Illinois, to preserve these sites and share their history through exhibits and educational programs. It also creates a national network to connect remaining Rosenwald Schools, enabling coordinated interpretation and resource-sharing across the country.
This bill limits how many patents brand-name drug companies can use to block generic versions of biological drugs (biologics). It caps the number of patents a brand company can assert in lawsuits against generic manufacturers at 20, with no more than 10 being patents issued after a specified date. Courts may allow more patents only in specific cases, such as if the generic company fails to provide required information or if there are material changes to the product. The law applies to new applications submitted after enactment and aims to reduce patent-related delays for cheaper generic biologics.
HR 6529, the Protecting Families from AI Data Center Energy Costs Act, mandates the Federal Energy Regulatory Commission (FERC) to hold a technical conference within 90 days of enactment. The conference will include AI data centers, utilities, and ratepayer advocates to develop strategies protecting residential and small commercial customers from rising energy costs caused by large energy users. FERC must then submit a report with recommendations to Congress within 180 days. This procedural bill directly affects households and small businesses facing potential rate increases due to AI data center energy demands.
This bill reauthorizes federal programs focused on preventing and responding to tick-borne diseases through 2026-2030, extending existing efforts beyond their previous expiration. It updates the National Strategy for Vector-Borne Diseases to emphasize identifying, reporting, preventing, and responding to these illnesses. The bill modifies two sections of the Public Health Service Act to continue funding for health departments working on vector-borne disease control. It directly affects public health programs and state/local health departments managing tick-borne disease prevention and response.
The AADAPT Act reauthorizes and expands Project ECHO grants to improve Alzheimer’s and dementia care through technology-enabled training. It specifically funds grants for healthcare providers in rural, frontier, or medically underserved areas to enhance early diagnosis, quality care, and provider retention for dementia patients. The bill authorizes $1 million annually (2027-2032) for these dementia-focused training programs, requiring funds to supplement - not replace - existing resources. This directly supports primary care providers licensed to serve underserved communities, using collaborative online learning to address care gaps.
This bill establishes the INCLUDE Project at the National Institutes of Health (NIH) to advance research on Down syndrome and related health conditions. It requires NIH to fund high-risk studies on trisomy 21, support inclusive clinical trials for people with Down syndrome across all ages, and investigate co-occurring conditions like Alzheimer’s disease and autoimmunity. The law mandates NIH coordination across its institutes, consultation with patient advocates, and biennial reports to Congress detailing funded research and its real-world applications. The project directly affects individuals with Down syndrome, their families, and medical researchers, aiming to improve diagnosis, treatment, and quality of life through targeted scientific efforts.
